Latest

Alzheimer’s disease

·July 27, 2020·5 min read

Flu and Pneumonia Vaccinations Tied to Lower Risk of Alzheimer’s

Being vaccinated against influenza was associated with a 17% reduction in Alzheimer's incidence. Pneumonia vaccinations given between the ages of 65 and 75, reduced Alzheimer's risk by up to 40%.

Featured Neurology

·July 20, 2020·3 min read

Older Adults Who Can Really Smell the Roses May Face Lower Likelihood of Dementia

Older adults with a higher ability to process sensations, including vision, olfaction, hearing, and touch, had half the risk of being diagnosed with cognitive decline than their peers who were less capable at sensory processing tasks.

Featured Neurology

·July 20, 2020·4 min read

Oxytocin Could Be Used to Treat Cognitive Disorders Like Alzheimer’s

Oxytocin, the so-called "love hormone," could help to treat cognitive disorders, including Alzheimer's disease. Researchers demonstrated oxytocin reversed the effects of amyloid-beta on hippocampal LTP in mice. The findings suggest oxytocin could be used as a therapeutic for the treatment of Alzheimer's disease and other dementias.

This shows a head made up of network nodes

Featured Genetics Neurology Open Neuroscience Articles

·July 18, 2020·5 min read

Adults With Alzheimer’s Risk Factors Show Subtle Alterations in Brain Networks Despite Normal Cognition

APOEe4, a gene associated with Alzheimer's disease risk, doesn't appear to directly affect memory performance or brain activity in older adults without cognitive impairment. However, the gene does seem to influence brain regions and systems that older at-risk adults activate to support successful memory recall.

This shows a brain made up of network nodes

Featured Genetics Neurology Neuroscience Psychology

·July 17, 2020·4 min read

Synapse-Saving Proteins Discovered, Opening Possibilities in Alzheimer’s and Schizophrenia

Study identified a new class of proteins that protect synapses from being destroyed. The findings have important implications for both Alzheimer's disease and schizophrenia.

Featured Neurology

·July 16, 2020·5 min read

A “Feeling” for Dementia?

People with subjectively felt memory deficits also exhibited measurable cognitive deficits that were associated with abnormalities in spinal fluid.

This is a stick and ball model of dopamine

Featured Neurology Open Neuroscience Articles

·July 15, 2020·5 min read

Dopamine Therapy Improves Cognitive Function in Alzheimer’s

Rotigotine, a drug that acts on dopamine transmission, improves cognitive function in patients with mild-to-moderate Alzheimer's disease. While the drug did not help improve memory, it did improve executive function in the frontal lobe and positively impacted the ability of patients to perform activities of daily living.

Featured Neurology Open Neuroscience Articles

·July 3, 2020·5 min read

Brain Iron Accumulation Linked to Cognitive Decline in Alzheimer’s

Iron accumulation in the brain's neocortex has been linked to cognitive decline in people with Alzheimer's disease.

Featured Neurology

·July 1, 2020·5 min read

Asthma Drug Salbutamol a Potential Alzheimer’s Treatment

Salbutamol, a common asthma medication, shows potential for the treatment of Alzheimer's disease. The drug is effective at reducing the accumulation of insoluble fibers of the tau protein.

Featured Genetics Open Neuroscience Articles

·June 24, 2020·5 min read

Protein in mitochondria appears to regulate health and longevity

Humanin, a peptide encoded in mitochondria, appears to have a beneficial impact on both health and longevity in both humans and animals. Higher levels of humanin in the body are associated with longer life spans and a reduced risk of neurodegenerative disorders, like Alzheimer's disease.

Featured Neurology Open Neuroscience Articles

·June 24, 2020·4 min read

Pulse pressure: A game changer in the fight against dementia

Elevated pulse pressure in blood traveling to the brain causes inflammation, oxidative stress, and apoptosis in the blood-brain barrier that leads to brain damage.

Featured Genetics Neurology

·June 23, 2020·5 min read

New gene may drive earliest brain changes in Alzheimer’s

Genetic analysis of almost 4,300 samples reveals a link between the appearance of amyloid deposits, APOE, and a novel gene called RBFOX1. Lower levels of RBFOX1 in the brain appear to be associated with increased amyloid and global cognitive decline over a person's lifetime.